Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bill H Chang

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Neoreviews|November 30, 2022
Fetal HepatomegalyJina Park, Devlynne Sasha Ondusko, Bill H Chang, et al.
Oncogene|June 1, 2018
Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALLMarilynn Chow, Lina Gao, Jason D MacManiman, et al.
Cancer Cell|November 17, 2012
Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemiaVincent T Bicocca, Bill H Chang, Behzad Kharabi Masouleh, et al.
Genome Medicine|November 30, 2013
Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicineDaniel Bottomly, Peter A Ryabinin, Jeffrey W Tyner, et al.
Genome Research|May 26, 2012
Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemiaTyrone Ryba, Dana Battaglia, Bill H Chang, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
EMBO Reports|July 4, 2019
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic nicheSherif Abdelhamed, John T Butler, Ben Doron, et al.
Pediatric Blood & Cancer|July 20, 2024
Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiationJ Connor Thellman, Milie M Fang, Tanaya Neff, et al.
British Journal of Haematology|February 4, 2012
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) studyBill H Chang, Stephanie G Willis, Linda Stork, et al.
Blood|September 8, 2020
Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALLJessica T Leonard, Yoko Kosaka, Pavani Malla, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Neoreviews|November 30, 2022
Fetal HepatomegalyJina Park, Devlynne Sasha Ondusko, Bill H Chang, et al.
Oncogene|June 1, 2018
Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALLMarilynn Chow, Lina Gao, Jason D MacManiman, et al.
Cancer Cell|November 17, 2012
Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemiaVincent T Bicocca, Bill H Chang, Behzad Kharabi Masouleh, et al.
Genome Medicine|November 30, 2013
Comparison of methods to identify aberrant expression patterns in individual patients: augmenting our toolkit for precision medicineDaniel Bottomly, Peter A Ryabinin, Jeffrey W Tyner, et al.
Genome Research|May 26, 2012
Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemiaTyrone Ryba, Dana Battaglia, Bill H Chang, et al.
Pediatric Hematology and Oncology|December 1, 2017
Investigating the biology of relapsed acute leukemia: Proceedings of the Therapeutic Advances for Childhood Leukemia & Lymphoma (TACL) Consortium Biology Working GroupDeepa Bhojwani, Michael J Burke, Terzah Horton, et al.
EMBO Reports|July 4, 2019
Extracellular vesicles impose quiescence on residual hematopoietic stem cells in the leukemic nicheSherif Abdelhamed, John T Butler, Ben Doron, et al.
Pediatric Blood & Cancer|July 20, 2024
Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiationJ Connor Thellman, Milie M Fang, Tanaya Neff, et al.
British Journal of Haematology|February 4, 2012
Imatinib resistant BCR-ABL1 mutations at relapse in children with Ph+ ALL: a Children's Oncology Group (COG) studyBill H Chang, Stephanie G Willis, Linda Stork, et al.
Blood|September 8, 2020
Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALLJessica T Leonard, Yoko Kosaka, Pavani Malla, et al.
Pageof 6